These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33050993)

  • 1. Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia.
    Tiscornia JE; Poggio TV; Feinsilber DG; Coleman AE
    Skinmed; 2020; 18(4):254-255. PubMed ID: 33050993
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposed use of thalidomide for the cytokine storm of COVID-19.
    Goihman-Yahr M
    Clin Dermatol; 2020; 38(4):508. PubMed ID: 32972614
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigating hypothiocyanite against SARS-CoV-2.
    Cegolon L
    Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Potential Therapeutic Options for COVID-19.
    Austin D; Okour M
    J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatments for COVID-19: where are we now?
    Mendes A
    Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
    [No Abstract]   [Full Text] [Related]  

  • 6. Curing COVID-19.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Oct; 20(10):1101. PubMed ID: 32919520
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment considerations for coronavirus (COVID-19).
    Reilly J
    Hosp Pract (1995); 2020 Aug; 48(3):119-120. PubMed ID: 32282262
    [No Abstract]   [Full Text] [Related]  

  • 8. Favipiravir, an antiviral for COVID-19?
    Coomes EA; Haghbayan H
    J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
    [No Abstract]   [Full Text] [Related]  

  • 9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 10. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management.
    Fekrazad R
    Photobiomodul Photomed Laser Surg; 2020 May; 38(5):255-257. PubMed ID: 32326830
    [No Abstract]   [Full Text] [Related]  

  • 11. Sofosbuvir as a potential option for the treatment of COVID-19.
    Nourian A; Khalili H
    Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals for COVID-19 and Breastfeeding.
    Anderson PO
    Breastfeed Med; 2020 Oct; 15(10):605-607. PubMed ID: 32936682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 15. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 16. Plea for multitargeted interventions for severe COVID-19.
    Gaborit BJ; Bergmann JF; Mussini C; Arribas JR; Behrens G; Walmsley S; Pozniak A; Raffi F
    Lancet Infect Dis; 2020 Oct; 20(10):1122-1123. PubMed ID: 32325035
    [No Abstract]   [Full Text] [Related]  

  • 17. Famotidine Against SARS-CoV2: A Hope or Hype?
    Ghosh R; Chatterjee S; Dubey S; Lavie CJ
    Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
    Alany RG
    Pharm Dev Technol; 2020 Jul; 25(6):649. PubMed ID: 32423342
    [No Abstract]   [Full Text] [Related]  

  • 20. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
    Jensen JD; Lynch M
    Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.